EIF2AK3 and glioblastoma: Furthermore, PERK-driven glucose metabolism has been shown to promote the immunosuppressive activity of monocyte-derived macrophages (MDMs) through histone lactylation, and combining such approaches with immunotherapy may effectively inhibit GBM progression 62.